{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:28:38Z","timestamp":1789457318345,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T00:00:00Z","timestamp":1441756800000},"content-version":"vor","delay-in-days":373,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jacc.2014.06.1170","type":"journal-article","created":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T15:45:18Z","timestamp":1409586318000},"page":"1005-1014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":167,"title":["Impaired Responsiveness to the Platelet\u00a0P2Y12 Receptor Antagonist Clopidogrel\u00a0in\u00a0Patients With Type 2 Diabetes and\u00a0Coronary Artery Disease"],"prefix":"10.1016","volume":"64","author":[{"given":"Dominick J.","family":"Angiolillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Jakubowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Ferreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Tello-Montoliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Rollini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Franchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Darlington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaloo","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiro","family":"Sugidachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore A.","family":"Bass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2014.06.1170_bib1","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","author":"Levine","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.06.1170_bib2","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.jacc.2013.01.014","volume":"61","author":"Anderson","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.06.1170_bib3","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O'Gara","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.06.1170_bib4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/CIRCINTERVENTIONS.111.966176","article-title":"New directions in antiplatelet therapy","volume":"5","author":"Ferreiro","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2014.06.1170_bib5","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","article-title":"Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives","volume":"49","author":"Angiolillo","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.06.1170_bib6","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","article-title":"Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate","volume":"56","author":"Bonello","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.06.1170_bib7","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2011.06.059","article-title":"Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data","volume":"58","author":"Brar","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.06.1170_bib8","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/CIRCULATIONAHA.111.029165","article-title":"Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial","volume":"124","author":"Price","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.06.1170_bib9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(13)61170-8","article-title":"Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a\u00a0prospective multicentre registry study","volume":"382","author":"Stone","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2014.06.1170_bib10","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.jacc.2010.02.031","article-title":"Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in\u00a0patients undergoing elective coronary stent placement","volume":"55","author":"Hochholzer","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.06.1170_bib11","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.jacc.2011.11.068","article-title":"Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) study","volume":"59","author":"Price","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.06.1170_bib12","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.2337\/diabetes.54.8.2430","article-title":"Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment","volume":"54","author":"Angiolillo","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jacc.2014.06.1170_bib13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jacc.2006.03.038","article-title":"Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment","volume":"48","author":"Angiolillo","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.06.1170_bib14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1160\/TH08-03-0136","article-title":"Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease","volume":"100","author":"Serebruany","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacc.2014.06.1170_bib15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.amjcard.2010.04.015","article-title":"Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary intervention","volume":"106","author":"Mangiacapra","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2014.06.1170_bib16","doi-asserted-by":"crossref","first-page":"784.e1","DOI":"10.1016\/j.ahj.2009.08.013","article-title":"The relation between platelet reactivity and glycemic control in diabetic patients with cardiovascular disease on maintenance aspirin and clopidogrel therapy","volume":"158","author":"Singla","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2014.06.1170_bib17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/CIRCULATIONAHA.109.913376","article-title":"Diabetes and antiplatelet therapy in acute coronary syndrome","volume":"123","author":"Ferreiro","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.06.1170_bib18","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.jacc.2008.07.068","article-title":"Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex\u00a0vivo","volume":"52","author":"Erlinge","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.06.1170_bib19","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1160\/TH10-10-0652","article-title":"Functional profile of the platelet P2Y12 signalling pathway in patients with type 2 diabetes mellitus and coronary artery disease","volume":"105","author":"Ueno","year":"2011","journal-title":"Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2014.06.1170_bib20","first-page":"S67","article-title":"Diagnosis and classification of diabetes mellitus","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2014.06.1170_bib21","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/CIRCULATIONAHA.106.667741","article-title":"Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study","volume":"115","author":"Angiolillo","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.06.1170_bib22","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1093\/eurheartj\/ehn287","article-title":"A\u00a0randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study","volume":"29","author":"Angiolillo","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.06.1170_bib23","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/eurheartj\/ehq494","article-title":"A\u00a0pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial","volume":"32","author":"Angiolillo","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.06.1170_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1538-7836.2004.01063.x","article-title":"Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases","volume":"3","author":"Aleil","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacc.2014.06.1170_bib25","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jacc.2005.02.092","article-title":"Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug","volume":"46","author":"Labarthe","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.06.1170_bib26","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jpba.2008.08.020","article-title":"Quantitative determination of clopidogrel active metabolite in human plasma by LC-MS\/MS","volume":"48","author":"Takahashi","year":"2008","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.jacc.2014.06.1170_bib27","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.jacc.2007.07.051","article-title":"Platelet\u00a0function monitoring in patients with coronary artery disease","volume":"50","author":"Gurbel","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.06.1170_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/eurheartj\/ehm545","article-title":"Prasugrel achieves greater and faster P2Y12 receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its\u00a0active metabolite in aspirin-treated patients with\u00a0coronary artery disease","volume":"29","author":"Wallentin","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.06.1170_bib29","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/CIRCULATIONAHA.107.740324","volume":"116","author":"Wiviott","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.06.1170_bib30","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jacc.2008.05.054","article-title":"Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel","volume":"52","author":"Ang","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.06.1170_bib31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1089\/ars.2005.7.256","article-title":"Lipid peroxidation in diabetes mellitus","volume":"7","author":"Dav\u00ec","year":"2005","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jacc.2014.06.1170_bib32","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1074\/jbc.M305474200","article-title":"IRS-1 mediates inhibition of Ca2+ mobilization by insulin via the inhibitory G-protein Gi","volume":"279","author":"Ferreira","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacc.2014.06.1170_bib33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/01.ATV.0000199519.37089.a0","article-title":"Platelet inhibition by insulin is absent in type 2 diabetes mellitus","volume":"26","author":"Ferreira","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2014.06.1170_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jacc.2011.02.040","article-title":"Impact of insulin receptor substrate-1 genotypes on platelet reactivity and cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease","volume":"58","author":"Angiolillo","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2014.06.1170_bib35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/01.mcg.0000190774.91875.d2","article-title":"Liver disease in patients with diabetes mellitus","volume":"40","author":"Harrison","year":"2006","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jacc.2014.06.1170_bib36","doi-asserted-by":"crossref","first-page":"378","DOI":"10.7326\/0003-4819-98-3-378","article-title":"Disorders of gastrointestinal motility associated with diabetes mellitus","volume":"98","author":"Feldman","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2014.06.1170_bib37","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ejim.2012.03.001","article-title":"Diabetic gastrointestinal autonomic neuropathy: current status and new achievements for everyday clinical practice","volume":"23","author":"Gatopoulou","year":"2012","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jacc.2014.06.1170_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.recesp.2011.04.008","article-title":"Impact of\u00a0adjunctive cilostazol therapy versus high maintenance dose of clopidogrel in suboptimal responders with diabetes mellitus","volume":"65","author":"Ferreiro","year":"2012","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.jacc.2014.06.1170_bib39","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.2337\/dc12-2510","article-title":"Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with diabetes","volume":"36","author":"Alexopoulos","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacc.2014.06.1170_bib40","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCINTERVENTIONS.110.960187","article-title":"Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease","volume":"4","author":"Capodanno","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacc.2014.06.1170_bib41","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.108.791061","volume":"118","author":"Wiviott","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2014.06.1170_bib42","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1093\/eurheartj\/ehq325","article-title":"Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"31","author":"James","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2014.06.1170_bib43","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198610163151602","article-title":"Platelet activation in unstable coronary disease","volume":"315","author":"Fitzgerald","year":"1986","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2014.06.1170_bib44","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.thromres.2008.01.021","article-title":"Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction","volume":"122","author":"Heestermans","year":"2008","journal-title":"Thromb Res"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714043289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109714043289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T11:03:05Z","timestamp":1565780585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109714043289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0735109714043289"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2014.06.1170","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired Responsiveness to the Platelet\u00a0P2Y12 Receptor Antagonist Clopidogrel\u00a0in\u00a0Patients With Type 2 Diabetes and\u00a0Coronary Artery Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2014.06.1170","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}